You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
振德醫療(603301.SH):2024年度淨利潤預增88.00%到98.09%
格隆匯 01-21 16:45

格隆匯1月21日丨振德醫療(603301.SH)公佈2024年度業績預增公吿,預計2024年度實現歸屬於上市公司股東的淨利潤37,300萬元至39,300萬元,同比增加88.00%到98.09%;公司預計2024年度實現歸屬於上市公司股東的扣除非經常性損益的淨利潤30,300萬元至32,300萬元,同比增加59.82%到70.37%。

公司預計2024年度實現營業收入42億元至43億元,較上年同期增加1.77%至4.19%。其中,受益於公司近年來渠道佈局、產品組合、供應鏈能力、品牌影響力、產品創新能力等方面的提升,預計2024年度公司剔除隔離防護用品(口罩、防護服、隔離衣、抗原檢測試劑盒等,以下簡稱“隔離防護用品”)後的核心業務收入和毛利率實現了快速增長,有利於公司業務長遠發展和盈利能力提升。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account